The Groupon cofounder’s precision medicine company, which uses AI-based diagnostics, has broadened its focus to infectious disease and cardiology in addition to cancer.
Stéphane Bancel says data showing 95% efficacy for his company’s vaccine means that it may be able to start distributing its vaccine in late December, pending a green light from the FDA.
The announcement that the Pfizer-BioNTech vaccine could be up to 90% effective against the coronavirus led to a surge in BioNTech’s stock, adding billions to the net worths of its founder Uğur Şahin and its largest investors, Thomas and Andreas Struen…
David Baker, whose protein design technology is being used to develop therapies for Covid-19 and cancer, received one of several awards to scientists from the Breakthrough Prize Foundation that add up to a combined total of $21.75 million.
Thousands of employees donned face masks to work around the clock in three daily shifts, seven days a week – making everything from insulin pen cartridges to miniature glass barrels and — most pressingly — millions of tiny sterile vials, each one small…
Thousands of employees donned face masks to work around the clock in three daily shifts, seven days a week – making everything from insulin pen cartridges to miniature glass barrels and — most pressingly — millions of tiny sterile vials, each one small…